Profile | GDS4284 / 216745_x_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 750.306 | 70 |
GSM687648 | Patient 402 control | 476.951 | 63 |
GSM687653 | Patient 403 control | 1011.81 | 75 |
GSM687658 | Patient 404 control | 867.048 | 72 |
GSM687663 | Patient 411 control | 1146.15 | 76 |
GSM687668 | Patient 422 control | 762.065 | 70 |
GSM687673 | Patient 424 control | 980.896 | 73 |
GSM687678 | Patient 425 control | 1209 | 76 |
GSM687683 | Patient 427 control | 1150.82 | 76 |
GSM687688 | Patient 428 control | 1102.93 | 75 |
GSM687695 | Patient 441 control | 488.974 | 61 |
GSM687699 | Patient 443 control | 831.146 | 71 |
GSM687704 | Patient 444 control | 1314.61 | 78 |
GSM687707 | Patient 448 control | 839.238 | 72 |
GSM687712 | Patient 449 control | 909.898 | 73 |
GSM687719 | Patient 450 control | 738.654 | 69 |
GSM687724 | Patient 451 control | 1188.94 | 77 |
GSM687728 | Patient 452 control | 901.495 | 73 |
GSM687646 | Patient 401 treated 24h | 927.236 | 72 |
GSM687649 | Patient 402 treated 24h | 454.577 | 62 |
GSM687665 | Patient 411 treated 24h | 1033.57 | 74 |
GSM687651 | Patient 402 treated 4 weeks | 828.46 | 71 |
GSM687667 | Patient 411 treated 4 weeks | 805.224 | 70 |
GSM687670 | Patient 422 treated 24h | 902.726 | 72 |
GSM687671 | Patient 422 treated 4 weeks | 873.516 | 72 |
GSM687654 | Patient 403 treated 24h | 849.611 | 72 |
GSM687675 | Patient 424 treated 24h | 938.938 | 73 |
GSM687685 | Patient 427 treated 24h | 766.598 | 70 |
GSM687656 | Patient 403 treated 4 weeks | 763.567 | 70 |
GSM687677 | Patient 424 treated 4 weeks | 1513.72 | 80 |
GSM687687 | Patient 427 treated 4 weeks | 623.321 | 67 |
GSM687692 | Patient 428 treated 4h | 1120.07 | 76 |
GSM687716 | Patient 449 treated 4h | 1044.32 | 75 |
GSM687722 | Patient 450 treated 4h | 657.032 | 67 |
GSM687680 | Patient 425 treated 24h | 638.636 | 67 |
GSM687690 | Patient 428 treated 24h | 537.083 | 65 |
GSM687700 | Patient 443 treated 24h | 1027.09 | 74 |
GSM687705 | Patient 444 treated 24h | 1141.07 | 76 |
GSM687714 | Patient 449 treated 24h | 923.672 | 73 |
GSM687721 | Patient 450 treated 24h | 286.189 | 52 |
GSM687682 | Patient 425 treated 4 weeks | 1266.3 | 77 |
GSM687694 | Patient 428 treated 4 weeks | 1208.06 | 76 |
GSM687702 | Patient 443 treated 4 weeks | 853.544 | 71 |
GSM687718 | Patient 449 treated 4 weeks | 1464.22 | 80 |
GSM687723 | Patient 450 treated 4 weeks | 966.647 | 74 |
GSM687661 | Patient 404 treated 4h | 1058.62 | 75 |
GSM687710 | Patient 448 treated 4h | 603.994 | 67 |
GSM687726 | Patient 451 treated 4h | 1129.63 | 76 |
GSM687730 | Patient 452 treated 4h | 4191.25 | 93 |
GSM687660 | Patient 404 treated 24h | 471.229 | 63 |
GSM687697 | Patient 441 treated 24h | 768.832 | 70 |
GSM687709 | Patient 448 treated 24h | 987.874 | 74 |
GSM687725 | Patient 451 treated 24h | 1278.05 | 78 |
GSM687729 | Patient 452 treated 24h | 793.279 | 72 |
GSM687727 | Patient 451 treated 4 weeks | 1287.42 | 78 |
GSM687731 | Patient 452 treated 4 weeks | 1213.76 | 77 |